Lightstone Ventures
Venture capital
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
4Deep-tech portfolio2 active
2Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Gossamer Bio
46Co-investorsShare a portfolio company
Portfolio · 4 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Ray Therapeutics | Biotech | Active | May 26, 2023 | $20.0M |
| Prelude Therapeutics | Biotech | Active | Aug 28, 2020 | $97.0M |
| Gossamer Bio | Biotech | Public | Sep 4, 2026 | $728.1M |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
Peer ranks
Portfolio size#108
Portfolio exits#103
Raises, 12 months#22
Co-investors#32
Co-investors
- Bay City CapitalVenture capital2 shared
- Boxer CapitalVenture capital2 shared
- Deerfield Capital ManagementVenture capital2 shared
- EcoR1 CapitalVenture capital2 shared
- Perceptive AdvisorsVenture capital2 shared
- Perceptive Life SciencesVenture capital2 shared
- RTW InvestmentsVenture capital2 shared
- Telegraph Hill PartnersVenture capital2 shared
- The Column GroupVenture capital2 shared
- Third Rock VenturesVenture capital2 shared
Sectors
- Biotech4
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.